| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |